Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • miroslav
    Junior Member
    • Feb 2011
    • 6

    #1

    Agilent capture baits

    I am setting up targeted sequencing using custom Agilent capture system. The design of the capture baits returned nearly 100,000 probes. The information is provided as BED file. Is there a good way of evaluating the design quality, other than manually inspecting location of 1000s of probes (), before committing to kit production? In particular, the coverage of different loci varies considerably - presumably on account of repeats and perhaps GC content variation (?). What are relative merits of bait boosting vs higher density tiling (1X density vs 2X density)?
    Answers and/or pointers to resources appropriate for novices would be gratefully appreciated.
    best
    miroslav
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Manually inspecting? IGV.

    More automated...I use coverageBed all the time to check one region versus another.

    Comment

    • miroslav
      Junior Member
      • Feb 2011
      • 6

      #3
      capture baits

      Thanks ECO for the pointers - slowly getting on top of this.
      Is there any resource that could explain benefits of different options in targeted capture probe design? For instance, bait boosting (by Agilent protocol) appears to help with high GC regions and orphan probes but has no effect on target coverage. The probe density appears to have moderate effect on coverage but at a significant cost in terms of number of probes required for the same target as one would expect. I would like to learn how to balance these things but not sure where to start.
      Any help would be appreciated
      Miroslav

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...